While most psychiatric patients are familiar with psychotherapy and medications, they may not be as familiar with TMS (transcranial magnetic stimulation) Psychiatry. TMS is a noninvasive procedure that uses magnetic fields to stimulate the brain to improve symptoms of depression and OCD. Clinical trials are also underway for additional brain disorders. TMS is typically used when other treatments have proven to be ineffective for mental health patients.
Providing patients with another option, BrainsWay – utilizing an innovative TMS technology – offers a non-invasive, efficacious, and well-tolerated treatment that activates deep brain structures using directed electromagnetic fields which generate excitation or inhibition of neurons inside the brain. BrainsWay represents the next-generation of TMS Psychiatry treatment for depression and OCD, achieving outcomes not thought possible with traditional medical solutions.
The Advantages of BrainsWay’s TMS Psychiatry
The advantages of TMS psychiatry – specifically BrainsWay’s FDA-cleared therapies for MDD and OCD – are the following:
Provide Patients with More Options
BrainsWay Deep TMS is a powerful treatment method that should be added as a viable alternative to doctors’ and patients’ existing list of potential treatment options. Deep TMS can be effective even where other treatment options have failed.
Safe & Effective
BrainsWay therapy has been demonstrated to be effective for many patients, has a favorable safety profile and is generally well-tolerated for the treatment of patients with MDD and OCD. Side effects are non-systemic, with the most common side effect being minor headaches which often dissipate over the course of the treatment.
BrainsWay’s treatment non-invasively stimulates the brain using brief magnetic fields. It does not require hospitalization or anesthesia.
Short, Clinically Proven Treatments
BrainsWay treatment sessions last around just 20 minutes, allowing for minimal disruption in the patient’s routine.
TMS Psychiatry Testimonials
To discover other patient’s experience with TMS psychiatry, please visit our video gallery to explore the many testimonials given by patients who have undergone our treatment. Click here.
Deep-TMS for MDD
BrainsWay D is successfully transforming the lives of patients suffering from Major Depressive Disorder (MDD). The U.S. Food and Drug Administration (“FDA”) cleared BrainsWay’s Deep TMS device for the treatment of depression in patients who failed to respond to antidepressant medications in their current episode of depression. BrainsWay D is effective even in treatment resistant depression. Individuals who failed to achieve relief for MDD using existing treatments may finally find relief with BrainsWay D. The safety and efficacy of depression therapy with BrainsWay’s device have been demonstrated extensively in clinical trials. Patients now have the option of receiving a comfortable, noninvasive treatment without the need for anesthesia or hospitalization, allowing them to preserve their quality of life. For more information about BrainsWay’s TMS Psychiatry option for MDD, click here.
Deep-TMS for OCD
BrainsWay OCD treatment, which has recently been FDA-cleared (De Novo), is changing the lives of OCD patients. BrainsWay now offers an efficacious, well-tolerated and non-invasive treatment that uses Deep Transcranial Magnetic Stimulation to treat OCD. The treatment performs magnetic stimulation of frontal brain structures and networks, targeting previously unreachable areas of the brain with its proprietary H7-coil, allowing it to effectively treat OCD in many patients. For more information about BrainsWay’s TMS Psychiatry options for OCD, click here.